已发表论文

3'-UTRNTRK2 的功能遗传变异与缺血性中风的风险有关

 

Authors Shi J, Sun Y, Hua J

Received 29 July 2020

Accepted for publication 30 September 2020

Published 12 November 2020 Volume 2020:13 Pages 577—584

DOI https://doi.org/10.2147/PGPM.S270319

Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 2

Editor who approved publication: Dr Martin Bluth

Background: Stroke is a leading cause of death and disability worldwide. It remains difficult to treat brain injury and improve functional rehabilitation after cerebral ischemia. Brain-derived neurotrophic factor (BDNF ) is involved in ischemic stroke (IS) through interactions in the CREB1-BDNF-NTRk2  pathway. In this study, we aimed to determine the association of NTRK2  gene polymorphisms and the effects of intergenetic interactions in the Chinese population.
Materials and Methods: A total of 400 patients diagnosed with IS and 400 healthy controls were enrolled for genotyping. Detailed sequence-based analysis was predicted through bioinformatical investigation. Polymorphisms associated with miRNA were analyzed by a dual-luciferase reporter assay system.
Results: Analysis of clinical characteristics revealed that IS was highly associated with exposure to cigarette smoking, alcohol intake, as well as metabolic diseases, such as diabetes, hypertension, and higher serum triglyceride concentration. Three polymorphisms in NTRK2  located in the 3ʹ-untranslated region (3ʹ-UTR) were genotyped. Logistic regression analysis showed that IS patients with rs11140793, rs7047042, and rs1221 polymorphisms had a higher risk of stroke and indicated a worse short-term recovery. The mRNA level of NTRK2  was suppressed in a mutant genotype compared with wild genotype. The suppression of NTRK2  was induced by the gain-of-binding ability of certain miRNAs through the direct binding of 3ʹ-UTR.
Conclusion: Our research indicated that, by influencing the expression of NTRK2 , the SNPs rs11140793, rs7047042, and rs1221 in the 3′UTR of NTRK2  can be used as risk factors for IS patients.
Keywords: bioinformatics, NTRK2 , ischemic stroke, homocysteine, miRNA